Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:**\n5-(5-(6-chloro-4-(4,5-dihydro-2‑oxazolyl)phenoxy)pentyl)-3-methyl isoxazole is a synthetic small molecule belonging to the class of phenol ethers and is structurally characterized by an isoxazole ring linked via a pentyl chain to a chlorinated phenoxy group bearing an oxazoline substituent. It has been referenced as "COMPOUND VII" and "Win‑53338" in chemical databases. The compound has been studied as an experimental agent but there are no publicly available data on its mechanism of action or therapeutic indication. No information about clinical development or approval status exists; it appears to be used primarily for research purposes[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(5-(6-chloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole.